Compare Marathon Digital Holdings Inc (MARA) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marathon Digital Holdings Inc vs ResMed Inc. — how do they compare? Marathon Digital Holdings Inc trades at $9.65 (market cap $3.83B), while ResMed Inc. trades at $230.05 (market cap $31.89B). The key difference: ResMed Inc. is far larger — about 8.3× Marathon Digital Holdings Inc's market cap, and ResMed Inc. pays a 1.16% dividend while Marathon Digital Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marathon Digital Holdings Inc for 22 Days and ResMed Inc. for 51 Days on average.
| MARA | RMD | |
|---|---|---|
Market Cap | $3.83B | $31.89B |
Volume | 47,742,698 | 618,314 |
Sector | Financials | Health |
52-Week High | $22.84 | $275.96 |
52-Week Low | $6.73 | $182.82 |
Typical Hold Time | 22 Days | 51 Days |
Enterprise Value | $5.87B | $31.24B |
Dividend Yield | — | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MARA stock trades at $9.91, down 4.34% today, showing bearish technical momentum despite recent volatility. The company faces significant fundamental challenges with a net income margin of -429.71% and consecutive quarterly earnings misses. Analyst sentiment remains divided with equal buy/hold ratings, while recent news highlights the stock's sensitivity to broader market movements and Bitcoin-related sector trends.
The outlook remains challenging due to persistent losses and negative profitability metrics. While the consensus price target of $13.25 suggests potential upside, investors face substantial execution risks amid heavy cash burn and competitive pressures in the technology sector.
ResMed (RMD) trades at $226.73, up 0.33% on the day, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming earnings report and positive analyst commentary on growth prospects.
The outlook is positive, driven by consistent earnings outperformance and a consensus price target of $242.70, implying upside. Key risks include competitive pressures and ongoing legal investigations. Institutional interest remains strong, with recent stake increases by funds. The stock's valuation metrics, such as a P/E of 21.74, appear reasonable given growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
